Gh Research Plc (GHRS)

$12.49

+0.68

(+5.76%)

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $11.49
    $12.79
    $12.49
    downward going graph

    8.01%

    Downside

    Day's Volatility :10.13%

    Upside

    2.31%

    downward going graph
  • $5.05
    $14.99
    $12.49
    downward going graph

    59.57%

    Downside

    52 Weeks Volatility :66.31%

    Upside

    16.68%

    downward going graph

Returns

PeriodGh Research PlcSector (Health Care)Index (Russel 2000)
3 Months
12.37%
6.5%
0.0%
6 Months
62.9%
7.1%
0.0%
1 Year
-6.27%
9.8%
0.0%
3 Years
-29.41%
14.2%
-20.2%

Highlights

Market Capitalization
620.7M
Book Value
$4.03
Earnings Per Share (EPS)
-0.62
Wall Street Target Price
32.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-11.27%
Return On Equity TTM
-14.31%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-42.0M
Diluted Eps TTM
-0.62
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.83
EPS Estimate Next Year
-1.18
EPS Estimate Current Quarter
-0.22
EPS Estimate Next Quarter
-0.24

Analyst Recommendation

Buy
    90%Buy
    9%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Gh Research Plc(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 156.2%

Current $12.49
Target $32.00

Technicals Summary

Sell

Neutral

Buy

Gh Research Plc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Gh Research Plc
Gh Research Plc
3.05%
62.9%
-6.27%
-29.41%
-39.58%
Moderna, Inc.
Moderna, Inc.
-1.67%
18.26%
-0.21%
-64.15%
752.69%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.46%
13.21%
45.59%
84.19%
244.2%
Novo Nordisk A/s
Novo Nordisk A/s
-11.0%
18.31%
61.56%
186.46%
423.59%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.85%
14.43%
39.88%
147.45%
195.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Gh Research Plc
Gh Research Plc
NA
NA
NA
-0.83
-0.14
-0.11
NA
4.03
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.35
31.35
1.46
44.44
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
44.28
44.28
2.36
3.43
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
16.98
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Gh Research Plc
Gh Research Plc
Buy
$620.7M
-39.58%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$45.3B
752.69%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$116.9B
244.2%
31.35
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$572.0B
423.59%
44.28
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
195.07%
31.85
39.46%

Insights on Gh Research Plc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 67.9%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 215.9%

Institutional Holdings

  • Bvf Inc

    19.99%
  • RA Capital Management, LLC

    12.02%
  • RTW INVESTMENTS, LLC

    6.39%
  • FMR Inc

    5.80%
  • Verition Fund Managegment, LLC

    2.17%
  • Cormorant Asset Management, LLC

    1.14%

Company Information

gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.

Organization
Gh Research Plc
Employees
49
CEO
Mr. Florian Schonharting M.Sc. (Econ)
Industry
Services

FAQs